Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 17, 2014

Primary Completion Date

February 22, 2017

Study Completion Date

March 22, 2017

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

Prednisolone

Prednisolone (5mg per kg) will be taken on two consecutive days, Friday and Saturday mornings each week with breakfast

Trial Locations (6)

32827

Nemours Hospital, Orlando

43205

Research Institute Center for Gene Therapy at Nationwide Children's Hospital, Columbus

63109

Washington University in Saint Louis, St Louis

75390

University of Texas South Western Medical Center of Dallas, Dallas

95817

University of California Davis, Sacramento

60611-2605

Laurie Children's Hospital Of Chicago, Chicago

All Listed Sponsors
collaborator

Nationwide Children's Hospital

OTHER

collaborator

Northwestern University Feinberg School of Medicine

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

University of California, Davis

OTHER

collaborator

Nemours Children's Hospital

OTHER

lead

Washington University School of Medicine

OTHER

NCT02167217 - Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter